Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume 24, Issue 2, Pages 93-102
Publisher
Springer Science and Business Media LLC
Online
2022-03-01
DOI
10.1007/s40272-022-00495-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
- (2021) Aisling Smith et al. Children-Basel
- Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis
- (2021) Esther J. S. Jansen et al. Frontiers in Pediatrics
- Selective Treatment of PDA in High-Risk VLBW Infants With Birth Weight ≤800 g or
- (2021) Thowfique Ibrahim et al. Frontiers in Pediatrics
- Regional variation in cost of neonatal intensive care for extremely preterm infants
- (2021) Asaph Rolnitsky et al. BMC Pediatrics
- Early PARacetamol (EPAR) Trial: A Randomized Controlled Trial of Early Paracetamol to Promote Closure of the Ductus Arteriosus in Preterm Infants
- (2021) Tim Schindler et al. Neonatology
- Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)
- (2021) Souvik Mitra et al. BMJ Open
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses
- (2021) Samaher Al-Shaibi et al. Journal of Comparative Effectiveness Research
- Envisioning a Better U.S. Health Care System for All: Coverage and Cost of Care
- (2020) Ryan Crowley et al. ANNALS OF INTERNAL MEDICINE
- Oral Paracetamol vs Oral Ibuprofen in Patent Ductus Arteriosus: A Randomized, Controlled, Noninferiority Trial
- (2020) Ashutosh Kumar et al. JOURNAL OF PEDIATRICS
- Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
- (2020) Carlo Dani et al. EUROPEAN JOURNAL OF PEDIATRICS
- Spontaneous Closure of the Ductus Arteriosus in Preterm Infants: A Systematic Review
- (2020) Johan C. A. de Klerk et al. Frontiers in Pediatrics
- PDA: To treat or not to treat
- (2019) Meera N. Sankar et al. Congenital Heart Disease
- Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)
- (2019) Melissa Liebowitz et al. Journal of Perinatology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: A systematic review and network meta-analysis of clinical trials and observational studies
- (2019) Ettore Marconi et al. PHARMACOLOGICAL RESEARCH
- Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants
- (2018) Souvik Mitra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial
- (2018) Rania A. El-Farrash et al. Journal of Maternal-Fetal & Neonatal Medicine
- Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants
- (2018) Varangthip Khuwuthyakorn et al. Paediatrics and International Child Health
- Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
- (2018) Tim Hundscheid et al. BMC Pediatrics
- Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms – a prospective randomized clinical trial
- (2018) Bharathi Balachander et al. Journal of Maternal-Fetal & Neonatal Medicine
- Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
- (2017) Manar Al-lawama et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units
- (2017) G. Michael Bixler et al. JOURNAL OF PEDIATRICS
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates
- (2016) Abd El-Rahman El-Mashad et al. EUROPEAN JOURNAL OF PEDIATRICS
- Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus
- (2016) Mohammad Mehdi Bagheri et al. Iranian Journal of Pediatrics
- Paracetamol Accelerates Closure of the Ductus Arteriosus after Premature Birth: A Randomized Trial
- (2016) Pia Härkin et al. JOURNAL OF PEDIATRICS
- Randomized Trial to Compare Renal Function and Ductal Response between Indomethacin and Ibuprofen Treatment in Extremely Low Birth Weight Infants
- (2016) Yuh Jyh Lin et al. Neonatology
- Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial
- (2016) Bo Yang et al. Experimental and Therapeutic Medicine
- Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial
- (2015) Swarup Kumar Dash et al. INDIAN PEDIATRICS
- Comparison of Oral Ibuprofen with Oral Indomethacin for PDA Closure in Indian Preterm Neonates: A Randomized Controlled Trial
- (2014) Sanju Yadav et al. PEDIATRIC CARDIOLOGY
- A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus
- (2013) Martin Kluckow et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Oral Paracetamol versus Oral Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Infants: A Randomized Controlled Trial
- (2013) Mehmet Yekta Oncel et al. JOURNAL OF PEDIATRICS
- Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial
- (2013) Dan Dang et al. PLoS One
- Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus
- (2012) Mi Jeong Heo et al. ARCHIVES OF PHARMACAL RESEARCH
- Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants
- (2011) Omer Erdeve et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus Arteriosus
- (2010) Tulin Gokmen et al. JOURNAL OF PEDIATRICS
- Global shortage and rationing of indomethacin: need to refine approach
- (2010) A Sehgal Journal of Perinatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More